Author

Faraz Farooq

Observed names: F.T. Farooq, Farooq, Faraz T

Institutions: University of Ottawa, Children's Hospital of Eastern Ontario

Observed institutions: Emirates College for Advanced Education, University of Ottawa, Children's Hospital of Eastern Ontario, CHEO Research Institute

ORCID: 0000-0001-8670-5009

Observed ORCID: 0000-0001-8670-5009

OpenAlex ID: A5053299748

p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR

2009 · Faraz Farooq, Sylvia Balabanian, et al. · Human Molecular Genetics · 92

PDF

Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway

2011 · Faraz Farooq, Francisco Abadía Molina, et al. · Journal of Clinical Investigation · 83

PDF

Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation

2013 · Faraz Farooq, Francisco Abadía-Molina, et al. · Human Molecular Genetics · 55

PDF

VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models

2014 · Jeremiah Hadwen, Duncan MacKenzie, et al. · Orphanet Journal of Rare Diseases · 14

PDF

Anisomycin Activates Utrophin Upregulation Through a p38 Signaling Pathway

2018 · Jeremiah Hadwen, Faraz Farooq, et al. · Clinical and Translational Science · 13

PDF

Sodium Channel Inhibitors Reduce DMPK mRNA and Protein

2015 · Luke Witherspoon, Sean O'Reilly, et al. · Clinical and Translational Science · 13

PDF

Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway

2011 · Faraz Farooq, Francisco Abadía Molina, et al. · Journal of Clinical Investigation · 8

PDF

Human Growth Hormone Increases SMN Expression and Survival in Severe Spinal Muscular Atrophy Mouse Model

2014 · Duncan MacKenzie, Fahad Shamim, et al. · Journal of Neuromuscular Diseases · 6

PDF

High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1)

2021 · Nafisa Neault, Sean O’Reilly, et al. · PLoS ONE · 4

PDF

Separating the Wheat from the Chaff: The Use of Upstream Regulator Analysis to Identify True Differential Expression of Single Genes within Transcriptomic Datasets

2021 · Jeremiah Hadwen, Sarah Schock, et al. · International Journal of Molecular Sciences · 2

Current and emerging treatment options for spinal muscular atrophy

2015 · Faraz Farooq, Alex MacKenzie · Degenerative Neurological and Neuromuscular Disease · 2

PDF

Repositioning Clinic-Ready Compounds for the Treatment of Spinal Muscular Atrophy

2017 · Faraz Farooq · CRC Press eBooks

T.P.8 Induction of SMN protein by combination of STAT5 and p38 kinase activating, clinic ready compounds for the treatment of SMA

2012 · F.T. Farooq, D. MacKenzie, et al. · Neuromuscular Disorders

Role of p38 and STAT5 Kinase Pathways in the Regulation of Survival of Motor Neuron Gene Expression for Development of Novel Spinal Muscular Atrophy Therapeutics

2012 · Farooq, Faraz T · uO Research (University of Ottawa)

Works count: 14

Citation count: 292

H-index: 7

I10-index: 6